These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8128602)

  • 21. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
    Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
    Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection.
    Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A
    J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.
    Heffner S; Kovács F; Klupp BG; Mettenleiter TC
    J Virol; 1993 Mar; 67(3):1529-37. PubMed ID: 8382308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant.
    Kit S; Awaya Y; Otsuka H; Kit M
    J Vet Diagn Invest; 1990 Jan; 2(1):14-23. PubMed ID: 1965296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
    Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
    BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
    Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
    Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells.
    Marchioli CC; Yancey RJ; Petrovskis EA; Timmins JG; Post LE
    J Virol; 1987 Dec; 61(12):3977-82. PubMed ID: 2824827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gD&gC-substituted pseudorabies virus vaccine strain provides complete clinical protection and is helpful to prevent virus shedding against challenge by a Chinese pseudorabies variant.
    Zhang C; Liu Y; Chen S; Qiao Y; Guo M; Zheng Y; Xu M; Wang Z; Hou J; Wang J
    BMC Vet Res; 2019 Jan; 15(1):2. PubMed ID: 30606159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral immunization of wild boar and domestic pigs with attenuated live vaccine protects against Pseudorabies virus infection.
    Maresch C; Lange E; Teifke JP; Fuchs W; Klupp B; Müller T; Mettenleiter TC; Vahlenkamp TW
    Vet Microbiol; 2012 Dec; 161(1-2):20-5. PubMed ID: 22832373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.
    van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP
    Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
    Kit M; Kit S
    Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
    Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
    Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus.
    Eloit M; Vannier P; Hutet E; Fournier A
    Arch Virol; 1992; 123(1-2):135-43. PubMed ID: 1312820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
    Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
    J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.